This study was conducted to assess the effects of dietary energy in late pregnancy and hormone therapy at weaning on plasma metabolite profile, litter performance, reproductive parameters, and embryo viability in the second pregnancy. A total of 23 first-parity sows at 75 d of pregnancy were randomly allocated to 4 treatments. Treatments were factorial (2 × 2) combinations of 2 nutritional strategies [standard-energy feed (SEF) and high-energy feed (HEF)] and 2 hormone therapies [600 IU eCG and 2.5 mg swine LH 72 h later (HO) and no hormone (WH)]. Sows were weighed weekly from 75 d of pregnancy until 3 d before farrowing; 1 d after farrowing; 7, 14, and 21 d into lactation; and at weaning. Back fat (BF) was measured at 75 d of pregnancy, 3 d before farrowing, and at weaning. Average daily gain and ADFI were also calculated. Plasma metabolites were analyzed after 82, 89, 96, and 103 d of pregnancy, at farrowing, and after 7, 14, and 21 d of lactation. Embryo viability was assessed after 4.55 d of second pregnancy. During pregnancy, HEF-treated sows displayed greater BW (P < 0.05) compared with SEF-treated females, but no differences were observed during lactation. There were no differences in BW of the piglets caused by the treatments. High-energy-treated females showed superior BF (P > 0.05) in all periods; however, significant differences were detected only at the prefarrowing measurement (P < 0.05). No differences in ADFI were observed during lactation. The SEF group showed positive ADG, whereas the HEF group showed negative ADG (0.216 vs. -0.266 kg/d for SEF and HEF, respectively; P < 0.05). Highenergy-treated sows presented greater concentrations of total cholesterol after 89 and 103 d of pregnancy and greater concentrations of high-density lipid cholesterol (HDL) after 89 and 96 d. At farrowing and 14 and 21 d of lactation, NEFA concentrations were greater (P < 0.05) in the HEF group. After hormone treatment, no differences were observed on weaning-to-estrus intervals and estrus duration. Greater mobilization of body reserves observed in the HEF group during lactation did not affect reproductive performance negatively, suggesting that metabolic status was adequate for the first lactational catabolism.
INTRODUCTION
Genetic improvement of swine enabled better reproductive performance, increased lean meat output, and produced more prolific sows. Prolific sows have greater deposition of lean tissue and limited capacity of feed intake (Thaker and Bilkei, 2005) . During lactation, mobilization of body reserves is necessary to compensate for reduced intake and meet the nutritional demand of milk production (Kim and Easter, 2001) .
First-parity sows have frequently been studied because of decreased performance on the next estrous cycle, increased weaning-to-estrus interval (Tantasuparuk et al., 2001 ), reduced ovulation rates and embryonic survival (Kemp and Soede, 2004) , and reduced litter size (Tantasuparuk et al., 2001) . Combined, these phenotypes are characteristic of the reproductive disorder known as "secondparity syndrome" (Vargas et al., 2006) . Zak et al. (1998) reported that lactational catabolism in the first-parity sow resulted in BW and back fat loss, even when sows were fed for ad libitum intake.
Follow-up of metabolic status throughout pregnancy in first-parity sows is a determining factor to improve fertility in the second parturition, and hormone therapy is one of the alternatives used to prevent impaired reproductive performance caused by lactational catabolism (Willis et al., 2003) . Hormone therapy is an important tool that can increase endogenous concentrations of gonadotropins and may result in greater chances of return to reproductive activity in first-parity sows (Candini, 2001; Portella, 2003) .
The association between differentiated nutritional management in the final quarter of pregnancy and the use of exogenous hormones seems to be able to positively influence second-parity syndrome in sows. Thus, the aim of this study was to assess the effect of higher-energy diet in late pregnancy and hormone therapy at weaning on plasma metabolite profile, litter size, subsequent embryo viability, and reproductive performance.
MATERIALS AND METHODS
The trial was performed in the Swine Research Laboratory of the School of Veterinary Medicine and Animal Science (FMVZ), University of Sao Paulo. The procedures and experimental use of animals were approved by the Animal Care and Use Committee of the School of Veterinary Medicine and Animal Sciences at the University of Sao Paulo, protocol number 1298/2008.
Experimental Design
Twenty-four commercial hybrid gilts (C23, Agroceres PIC, Rio Claro, Brazil) were individually penned and used in a complete randomized design experiment.
A 2 × 2 treatment factorial design was used, which consisted of 2 nutritional treatment strategies beginning at 75 d of pregnancy and 2 hormone therapies administrated at weaning. Nutritional strategies were standard-energy feed (SEF) and high-energy feed (HEF; Table 1 ). Hormone therapies were 600 IU eCG plus 2.5 mg swine LH (intramuscular injection) 72 h later (HO) and no hormone (WH). For each treatment combination (SEFHO, SEF-WH, HEFHO, HEFWH), 6 gilts were used.
Diets
After AI and during the first 35 d of pregnancy, gilts of both groups were fed twice a day, totaling 2.0 kg/d of a standard-energy diet containing 13.8% CP and 12.27 MJ/ 4 Pregnancy feed unit supplies (per kg of product) folic acid 38 mg, pantothenic acid 346 mg, Hidroxitolueno Butilado (BHT) 12 mg, biotin 2.66 mg, calcium 220 g, cobalt 4.4 mg, copper 375 mg, choline 9,000 mg, iron 625 mg, phosphorus 80 g, iodine 35 mg, manganese 1,000 mg, niacin 520 mg, selenium 11.90 mg, sodium 49 g, vitamin A 400,000 IU, vitamin B1 53 mg, vitamin B12 666 µg, vitamin B2 102.4 mg, vitamin B6 53 mg, vitamin D3 100,000 IU, vitamin E 880 mg, vitamin K3 88 mg, zinc 1.875 mg.
5 Lactation feed unit supplies (per kg of product) folic acid 42 mg, pantothenic acid 379 mg, BHT 14 mg, biotin 2.92 mg, calcium 220 g, cobalt 5 mg, copper 450 mg, choline 13,750 mg, iron 750 mg, phosphorus 75 g, iodine 42 mg, manganese 1,200 mg, niacin 568 mg, selenium 13 mg, sodium 49 g, vitamin A 437, 000 IU, vitamin B1 58 mg, vitamin B12 729 µg, vitamin B2 112 mg, vitamin B6 58 mg, vitamin D3 109, 000 IU, vitamin E 962 mg, vitamin K3 96 mg, zinc 1.875 mg. kg of ME (Table 1) . From 35 to 75 d of pregnancy, the quantity of feed was adjusted according to BCS. Body condition score was divided into 5 classes: 1 = very thin, 2 = thin, 3 = normal, 4 = fat, and 5 = very fat. Females that showed BCS equal to or less than 2 received more feed to reach score 3. At 75 d of pregnancy, nutritional strategy treatments were initiated. Specifically, SEF animals (n = 11; 1 gilt died) were fed 2.5 kg•gilt -1 •d -1 of the standardenergy (NRC, 1998) diet that contained 13.8% CP and 12.27 MJ/kg of ME, and HE animals (n = 12) received 2.9 kg•gilt -1 •d -1 of a diet that contained 17.25% CP and 13.41 MJ/kg of ME, providing a 25% increase in ME in the diet ( Table 1) . At 3 d before farrowing, gilts were fed 1.5 kg/d of their treatment feed and an additional 0.5 kg/d of wheat bran. At the first 24 h after farrowing, sows were fed 1.5 kg/sow of lactation feed containing 21.33% CP and 14.26 MJ/kg of ME, and this amount was gradually increased until 120 h. Afterward, sows were fed lactation diets ad libitum until weaning. Fresh feed was offered at 0700, 1100, 1500, and 1800 h, in approximately equal amounts, with more feed placed in the feeders at any time to make feed always available. Uneaten feed was removed and weighed each day before the morning feeding.
Animal Management
At the moment of AI, gilts of both groups had similar BW and age (144 ± 6.49 kg and 212 ± 2.44 d), making up a homogenous sample. Gilts were checked for standing estrus by placing an intact boar into the pen for 15 min/d. Gilts were bred 3 times by AI with pooled semen on their last third of estrus. Approximately 32 d after AI, pregnancy was detected using a real-time ultrasound (Scanner 100, 5 MHz transducer, Pie Medical, Maastricht, the Netherlands). At approximately 107 d of pregnancy, gilts were moved into individual crates in rooms with 8 farrowing crates. Litter size was standardized until the third day after farrowing by the transference of piglets between sows of the same treatment. Routine procedures (teeth clipping, tail docking, ear notching, and iron injection) were conducted 2 d after farrowing, and no creep feed was offered. Sows were weaned approximately 23 d into lactation.
Performance
Body weight was measured at 75, 82, 89, 96, 103 , and 107 d of pregnancy, 3 d before farrowing (prefarrowing, PF), and 1 d after farrowing. During lactation, sows were weighed weekly after the morning feed was offered (7, 14, and 21 d of lactation and at weaning). Back fat (BF) was measured by ultrasound (5 MHz transducer) at P2 position at 75 d of pregnancy, at 3 d PF, and at weaning. Average daily gain and ADFI were assessed from these data. Females that did not show estrus until 12 d after weaning were diagnosed in anestrus. Artificial insemination was performed as in the first pregnancy. Piglets were individually weighed weekly after birth.
Plasma Metabolite Profile
Blood samples were collected from a jugular vein of gilts at 82, 89, 96, and 103 d of pregnancy, at farrowing, and at 7, 14, and 21 d into lactation. Samples were centrifuged at 2,000 × g at ≈25°C for 15 min, and serum was stored at -20°C for later analyses. The following assays were performed to determine the metabolic profile: triglycerides, total cholesterol (TC), high-density lipid cholesterol (HDL), NEFA, and β-hydroxybutyrate (BHB). Low-density lipid cholesterol (LDL) and very low density lipid cholesterol (VLDL) concentrations were determined indirectly by the following equations (Friedewald et al., 1972) : VLDL cholesterol (mg/dL) = triglyceride concentration/5, and LDL cholesterol (mg/dL) = total cholesterol − (HDL cholesterol + VLDL cholesterol).
Total cholesterol analyses were performed with commercial kits (Laborlab, Sao Paulo, Brazil). The BHB were measured using an automatic biochemistry analyzer (Automatic System of Biochemistry Model-SBA-200 -Modern Laboratory Equipment Company, MLEC -Barueri, Sao Paulo, Brazil) and NEFA were measured in micro-plates and read with a micro-plate reader (ASYS Brand, Model Expert Plus UV-340-Analytic, Biochrom Ltd., Cambridge, UK) using kinematic enzymatic kits (BHB, RANBUT d-3-hydroxybutyrate test kit, Randox Laboratories Ltd, Co Antrim, UK and NEFA test kits, Randox Laboratories Ltd, Co Antrim, UK).
For HDL concentration analysis, 200-μL samples were pipetted into 2.5-mL tubes together with 100 μL of a single precipitating reagent (MLEC-1763, Modern Laboratory Equipment Company) in a 2:1 ratio and were manually mixed by gentle inversion for 20 s. Samples were allowed to rest for 10 min. Subsequently, prepared samples were centrifuged at 1,025 × g at ≈25°C for 15 min, and the HDL molecules linked to cholesterol were determined by an automatic biochemistry analyzer (Automatic System of Biochemistry Model-SBA-200 -Modern Laboratory Equipment Company, MLEC -Barueri, Sao Paulo, Brazil). Intra-and interassay CV ranged from 2% to 5% and were determined for the analyses of plasma metabolites to control and assess the reliability of the results.
Reproductive Variables
Embryo Viability. Sows were killed by electronarcosis at 4.55 ± 0.92 d of their second pregnancy. Before electronarcosis, an AI pipette filled with silicon was placed in the cervix of each sow to prevent urine reflux to the uterus and possible damage to the embryos. The reproductive tract was removed by incision on the linea alba, soon after bleeding. Ten milliliters of PBS added to 1% fetal bovine serum (FBS) were injected in the oviduct infundibulum. The contents of the oviduct were massaged toward the uterine horn, and the oviduct was excised by cutting the uterotubal junction, where 40 mL of PBS with 1% FBS were injected after the cut. The fluid used in the flushing was drained and placed in 50-mL labeled polypropylene tubes. Samples were then subjected to embryo viability analysis using a stereomicroscope (20× magnification). Recovered embryos were kept at 37°C in tissue culture media (TCM 199) added to 3 mg/mL of BSA. Embryos were washed 3 times in PBS and incubated for 10 min in a solution with 5 mg/mL Hoechst 33342 (Hoechst 33342, Molecular Probes, Eugene, OR) and 10 µg/mL propidium iodide (PI; Sigma-Aldrich, St Louis, MO) in the dark. Embryos were washed in PBS, placed with glycerol on glass slides, covered with cover slips, and evaluated under an epifluorescence microscope (IX 81, Olympus, Tokyo, Japan; Papaioannou and Ebert, 1988) . Embryo viability was determined by the percentage of viable blastomeres stained with Hoechst but not by PI because PI staining indicates cell death.
Percentages of Weaning-to-Estrus Interval, Estrus Duration, Ovulation Rate, and Anestrus. Weaning-toestrus interval was defined as the period between weaning and the next estrus. At the moment of weaning, animals received hormone treatments [600 IU eCG and 2.5 mg swine LH 72 h later (HO) or no hormone (WH)].
Estrus duration was defined as the period when the gilt is in standing estrus. The ovulation rate was determined by counting corpora lutea found in the right and left ovaries after gilts were killed. Anestrus was determined when gilts did not show estrus after being with the male until the 12th day after weaning.
Statistical Analysis
The characteristics BW, back fat, ADFI, and ADG were influenced only by SEF and HEF dietary treatments. These characteristics were analyzed in different weeks, with each week considered a variable. In this way, time was not included in the model, and only nutritional strategies were considered as fixed effects, with no interaction between nutritional strategies and time. Plasma metabolite profiles were analyzed in a repeated-measure model with these fixed effects: nutritional strategies, time, and interaction between nutritional strategies × time.
Weaning-to-estrus interval, estrus duration, ovulation rate, occurrence of anestrus, and embryo viability were evaluated after the hormone treatments, and therefore, we considered nutritional strategies, hormone therapies, and the interaction between nutritional strategies × hormone treatments as fixed effects.
Data related to performance during pregnancy and lactation, weaning-to-estrus interval, estrus duration, ovulation rate, and embryo viability were analyzed using the PROC GLM function (SAS Inst. Inc., Cary, NC), with initial and postfarrowing weights as covariates, respectively. Data on plasma metabolite profile were analyzed by repeated measure using PROC MIXED. The dependent variable related to the occurrence of anestrus was analyzed by means of Fisher's exact test. Differences were considered significant at P < 0.05, and all results are expressed as means ± SEM.
RESULTS
Of the 24 sows that started the experiment, 23 successfully completed their lactation. One SEF-treated sow died 3 d before farrowing, and 1 sow in the SEFWH group died 3 d after weaning because of intense gastric hemorrhage, which was evidenced in the postmortem examination. Because of this, the number of females in this treatment was reduced to 4.
Performance
Beginning on d 82 of pregnancy, HEF-treated gilts displayed greater BW (P < 0.05; Table 2 ); this advantage increased with time until the moment before farrowing. The difference in BW between treatments did not continue throughout lactation. Higher-energy animals presented the greatest loss in BW during lactation (P < 0.05), and ADG was greater (P < 0.05) for the HEF group between 75 and 82 d, 89 and 96 d, and 75 d and PF (Table 3) . Only the interval between d 103 and PF showed no differences between groups (P > 0.05). Back fat was greater (P < 0.05) for HEF in the PF period (P < 0.05), and SEF showed a reduction in BF throughout pregnancy (Table 2) . Although BF variation was negative in HEF, it was similar to that of SEF animals. Average daily feed intake was similar in both treatments during the whole study (Table 3) .
No differences were observed in piglet development, with similar BW loss or gain during the whole study (Table  2) . Moreover, reproductive parameters at farrowing were similar between treatments, total pigs born/litter (12.64 ± 1.13 vs. 13.83 ± 0.38 for SEF and HEF, respectively), and pigs born alive (11.36 ± 1.06 vs. 12.58 ± 0.31 for SEF and HEF, respectively). Differences were observed (P < 0.05) regarding the percentage of stillbirths (0.18 ± 0.12 vs. 0.92 ± 0.31 for SEF and HEF, respectively).
Plasma Metabolite Profile
All blood biochemistry analyses, except for BHB concentration, showed the effect of time in both pre-and postfarrowing periods (P < 0.05; Table 4 ). No statistical dif-ferences were observed for BHB concentrations. Although triglyceride concentrations increased until d 7 of lactation, followed by a sharp decline at farrowing and an increase during lactation in favor of the HEF group, significance was only observed in the first week of lactation (Fig. 1) .
Total cholesterol in HEF was greater (P < 0.05) than SEF in PF, 94.84 ± 2.88 vs. 77.72 ± 1.84 mg/dL, respectively. In the weekly analyses, HEF was greater (P < 0.05) than SEF from d 89 of pregnancy to farrowing. During lactation, values were similar for both treatments (Fig. 2) . High-density lipid cholesterol showed interaction between treatment and time in the pre-and postfarrowing periods. High-energy-treated gilts showed the greatest (P < 0.05) concentrations of HDL after 89 and 96 d of pregnancy. In the postfarrowing period, the opposite occurred, with SEF showing the greatest (P < 0.05) concentrations after 7 d of lactation (Fig. 3) .
High-energy treated sows showed the greatest (P > 0.05) concentrations of LDL in the prefarrowing period. The effect of time was not observed in the same period, with a decline in LDL cholesterol until 103 d of pregnancy and an increase at farrowing. In the postfarrowing period, there was a constant increase in LDL cholesterol for both treatments (Fig. 4) . Very low density lipid cholesterol was only affected by time, in both the pre-and postfarrowing periods. A statistical difference (P < 0.05) was observed in the first week of lactation (Fig. 5) .
Nonesterified fatty acid concentrations showed the effect of the interaction (P < 0.05) in the prefarrowing period, with a difference at farrowing (P < 0.05). In the evaluation after 14 and 21 d of lactation, as well as in the evaluation of the whole experimental period, animals of the HEF group showed the greatest (P < 0.05) NEFA concentrations (Fig. 6 ).
Reproductive Variables
There was no difference (P > 0.05) between the treatments for any weaning-to-estrus interval, and no interaction was observed between treatment and time either (Table 5). Four females did not return to estrus until 12 d after weaning and were characterized as being anestrus. Estrus duration was the longest (P > 0.05) in sows that received the SEFWH. One sow in the SEFWH group died 3 d after weaning because of intense gastric hemorrhage, which was evidenced in the postmortem examination. Because of this, the number of females in this treatment was reduced to 4.
There were no differences in ovulation rates and embryo viability (Table 5) . As for the percentage of fertilized structures (embryos with 2 or more blastomeres) in the total number of structures recovered (not including fertilized oocytes), values were very close to significance for the interaction between the factors (P = 0.085). Regarding fertilized structures recovered, it was possible to observe embryos from the 2-cell stage to the blastocyst stage. Similar to ovulation rates, there was a large variation between treatments for the number of collected structures. However, no statistical significance was observed. The percentage of live cells was not different (P > 0.05) between the treatments; however, it was reduced in SEF sows.
DISCUSSION
Energy and protein are substrates that come from the diet, or even from body reserves, and are essential for physiological events (Einarsson and Rojkittikhun, 1993) . When ingested in excess, they are stored as lipids: triglycerides in the adipocytes, glycogen in muscles and liver, and body protein.
Thus, the differences observed between SEF-and HEF-treated sows regarding ADG during pregnancy and lactation were expected and so were the possible effects on reproductive performance after weaning. However, no effects on reproductive performance were observed in this study. Body weight of sows during pregnancy was very similar to the results reported by Xue et al. (1997) , who reported greater ADG in animals submitted to an experimental treatment with greater energy levels and larger amounts of feed. This difference in energy levels and amount of feed, together with differences in the genetic composition of the animals, probably resulted in the discrepancies in relation to our study.
In spite of the animals in the HEF group being heavier in the prefarrowing period, there were no differences in ADFI during lactation, different from data in the literature (Xue et al., 1997) . Reduced intake may be more evident in sows with greater fat reserves, possibly because of the modulation of several endocrine factors, such as insulin and leptin (Eissen et al., 2000) .
When lactation is considered, SEF-treated sows presented positive ADG (0.216 ± 0.277 kg/d), whereas HEF sows showed negative ADG (-0.266 ± 0.306 kg/d). However, these findings did not represent marked catabolism because reproductive indices of both groups were similar.
The lack of difference in litter size was expected, especially in total pigs born/litter, because of the homogenous BCS of the first-parity sows. The greater incidence of stillbirths in HEF-treated sows may be justified by the greater number of births in this treatment, increasing the length of farrowing and predisposing piglets to fetal distress and death. A relationship between energy intake during pregnancy and increased BW at birth or piglet ADG was not observed either, corroborating data from Coffey et al. (1994) .
The concentration of triglycerides during pregnancy presented a similar pattern in both groups, with HEF showing numerical advantage and evidencing greater energy intake. Hultén et al. (2002) similarly observed that regardless of the level of catabolism presented by sows, Figure 6 . Nonesterified fatty acid during pre-and postfarrowing periods in first-parity sows fed with either a standard-energy (SEF; diamonds) or highenergy (HEF; squares) diet. *The HEF sows had a greater (P < 0.05) NEFA concentration than the SEF sows. triglyceride concentrations remained similar throughout pregnancy. At the moment of farrowing, a marked reduction in the concentration of serum triglycerides was observed because of fasting.
Total cholesterol was greater in HEF-treated sows in the PF period, a result of greater energy intake. Total cholesterol reduction presented by both groups between 82 d of pregnancy and the moment of farrowing was mainly due to the reduction in LDL cholesterol and, after 103 d of pregnancy, by the drop in HDL. During lactation, the increase in all cholesterol fractions was in agreement with the gradual increase observed in total cholesterol concentrations.
The increase until d 103 of pregnancy with a later decline in VLDL cholesterol was similar to that of triglycerides once VLDL cholesterol takes part in the transport of triglycerides from the liver. Grundy and Denke (1990) reported that overfeeding increases the concentrations of VLDL cholesterol produced and secreted by the liver. This is due to the increase in the postprandial influx of energy to this organ and to the greater availability of FFA during fasting.
According to Allan et al. (2001) , there is evidence that in pigs most cholesterol esters found in LDL come from the synthesis of new cholesterol instead of only from the catabolism of VLDL cholesterol, as occurs in humans. This level of independence between LDL and VLDL cholesterol may explain the difference in the evolution of these 2 variables, especially during pregnancy. During this phase, the HEF group showed greater serum concentrations of LDL, increasing its availability to the cells. Gradual reduction, as pregnancy progresses, may be linked to the greater incorporation of LDL cholesterol particles by the cells, as occurs in progesterone and estradiol synthesis. This incorporation of LDL cholesterol increases from the start of the final quarter of pregnancy to the moment of farrowing (Robertson and King, 1974) . Greater concentrations of intracellular cholesterol reduce the transcription of the gene that encodes the LDL cholesterol receptor, decreasing cholesterol capture from blood (Nelson and Cox, 2006) . As a result, the increase in intracellular cholesterol caused by greater availability of this compound during lactation may have negatively interfered with the use of LDL cholesterol by the cells, increasing LDL concentration during this phase. High-density lipid cholesterol presented an evolution that is similar to the triglyceride and VLDL cholesterol profiles cited above. High-density lipid cholesterol concentrations were greater in the HEF treatment after 89 and 96 d of pregnancy, as a result of greater intake. This increase led to greater concentrations of VLDL cholesterol chylomicrons and more intense reverse flow of cholesterol. This event may also be, in part, responsible for the lower concentrations of LDL during these weeks.
Nonesterified fatty acid concentrations were very similar during pregnancy and were only greater during farrowing, which was responsible for the difference between the treatments in the prefarrowing period. The greater NEFA concentrations at the moment of farrowing, mainly for the HEF treatment, were similar to those obtained by Oliviero et al. (2009) , but there was no effect of pregnancy diet on feed intake during lactation.
Although there were no differences in any of the evaluations, the HEF group showed slightly greater BHB concentrations. This observation was more evident at the moment of farrowing, when liver production of ketone bodies to supply more energy to the tissues was apparent. According to Revell et al. (1998) , mainly in the third and fourth weeks of lactation, plasma concentrations of BHB may be connected to greater mobilization of fat reserves to respond to the high-energy requirements for milk production throughout lactation and to the adaptation of the diet that may have led to decreased mean BHB concentrations after farrowing.
Weaning-to-estrus interval was similar in all treatments and similar to data in the literature (Poleze et al., 2006) . As for anestrus, hormone treatment, mainly SEFHO, improved postweaning follicle development and may have induced ovulation in females that, without the treatment, would have not reached the degree of follicle development necessary for ovulation and would have shown a lower, albeit not significant, ovulation rate (Do Lago et al., 2005) .
The association of the hormone with high energy (HEFHO), although not significant, showed a numerical difference in the percentage of fertilized structures compared to other treatments. These data are similar to those reported by Do Lago et al. (2005), who evaluated the simultaneous use of flushing and hormones (eCG and LH) in the first estrus of gilts and verified that greater viability of 5-d embryos was only related to flushing. An intermediate response was observed using flushing and hormone treatment. The worst results in the study by Do Lago et al. (2005) were observed with hormone treatment alone. The same result is suggested by the findings of the present study, given the evidence that HEF-treated sows would be in a different metabolic status when compared with the SEF group, but there were no differences between any of the treatments. The characteristics of fertilized structures were consistent with this intermediate result, which was caused by a combination of nutritional status and gonadotropin action.
Dietary energy supplementation offered in the final quarter of pregnancy in first-parity sows was not able to prevent greater mobilization of body reserves. However, it did not affect postweaning reproductive performance negatively, suggesting that their metabolic profile was adequate for the first lactational catabolism.
